News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
354,055 Results
Type
Article (20097)
Company Profile (139)
Press Release (333819)
Section
Business (113039)
Career Advice (869)
Deals (20265)
Drug Delivery (89)
Drug Development (52838)
Employer Resources (79)
FDA (8306)
Job Trends (7997)
News (198476)
Policy (18489)
Tag
Academia (774)
Alliances (30563)
Alzheimer's disease (596)
Approvals (8269)
Artificial intelligence (76)
Bankruptcy (172)
Best Places to Work (5686)
Biosimilars (67)
Biotechnology (62)
Breast cancer (51)
Cancer (493)
Cardiovascular disease (53)
Career advice (707)
Cell therapy (74)
Clinical research (43304)
Collaboration (180)
Compensation (62)
COVID-19 (1153)
Data (504)
Diabetes (87)
Diagnostics (2107)
Drug pricing (90)
Earnings (40875)
Employer resources (73)
Events (50485)
Executive appointments (166)
FDA (8549)
Funding (136)
Gene therapy (82)
GLP-1 (473)
Government (1894)
Healthcare (6375)
Infectious disease (1199)
Inflammatory bowel disease (70)
Interviews (114)
IPO (7985)
Job creations (2498)
Job search strategy (650)
Layoffs (250)
Legal (4393)
Lung cancer (93)
Manufacturing (116)
Medical device (2849)
Medtech (2853)
Mergers & acquisitions (12295)
Metabolic disorders (305)
Neuroscience (749)
NextGen Class of 2024 (2444)
Non-profit (932)
Northern California (579)
Obesity (199)
Opinion (172)
Patents (68)
People (34385)
Pharmaceutical (75)
Phase I (13454)
Phase II (18402)
Phase III (14700)
Pipeline (148)
Podcasts (53)
Policy (65)
Postmarket research (1648)
Preclinical (4787)
Radiopharmaceuticals (163)
Rare diseases (123)
Real estate (3396)
Regulatory (12896)
Research institute (845)
Resumes & cover letters (138)
Southern California (528)
Startups (2191)
United States (5514)
Vaccines (212)
Weight loss (177)
Date
Today (113)
Last 7 days (426)
Last 30 days (1533)
Last 365 days (19140)
2024 (16268)
2023 (21036)
2022 (28342)
2021 (29274)
2020 (27271)
2019 (21480)
2018 (16669)
2017 (18569)
2016 (17509)
2015 (20333)
2014 (16098)
2013 (13765)
2012 (14775)
2011 (15091)
2010 (13836)
Location
Africa (424)
Arizona (50)
Asia (33300)
Australia (4343)
California (1290)
Canada (730)
China (145)
Connecticut (53)
Europe (55050)
Florida (169)
Illinois (129)
Indiana (107)
Kansas (59)
Maryland (231)
Massachusetts (1136)
Minnesota (93)
New Jersey (515)
New York (418)
North Carolina (358)
Northern California (579)
Ohio (60)
Pennsylvania (332)
South America (648)
Southern California (528)
Texas (159)
Washington State (127)
354,055 Results for "intec pharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
Essential Pharma announces that it has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd.
April 9, 2024
·
5 min read
Press Releases
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
October 1, 2024
·
5 min read
Press Releases
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
·
1 min read
Pharm Country
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
UroGen Pharma Ltd. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants.
June 17, 2024
·
4 min read
Business
UroGen Pharma Appoints David Lin as New Chief Commercial Officer
UroGen Pharma Ltd. today announced that David Lin will join UroGen as its Chief Commercial Officer and member of the Executive Leadership Team.
June 3, 2024
·
11 min read
Deals
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 7, 2024
UroGen Pharma Ltd. today announced the grants of inducement restricted stock units (“RSUs”) and an option (“Option”) to 15 new employees in connection with their employment with UroGen.
June 7, 2024
·
2 min read
Pharm Country
UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024
UroGen Pharma Ltd. today shared additional details about the upcoming ENVISION virtual data event on Thursday, June 13, 2024, at 11:00 a.m. Eastern Time.
June 6, 2024
·
4 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Deals
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024.
May 23, 2024
·
4 min read
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
Nxera Pharma Co. Ltd, announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neurological diseases, resulting in a payment of US$10 million to Nxera.
June 26, 2024
·
3 min read
1 of 35,406
Next
